Gender Disparities in Patients With Alcoholic Liver Disease Evaluated for Liver Transplantation.
Female
Follow-Up Studies
Humans
Liver Diseases, Alcoholic
/ epidemiology
Liver Transplantation
/ methods
Male
Middle Aged
Morbidity
/ trends
Prognosis
Retrospective Studies
Risk Factors
Sex Distribution
Sex Factors
Survival Rate
/ trends
Transplant Recipients
/ statistics & numerical data
United States
/ epidemiology
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
pubmed:
10
7
2019
medline:
30
9
2020
entrez:
9
7
2019
Statut:
ppublish
Résumé
The morbidity and mortality from alcohol-related liver disease (ALD) is increasing in the United States. However, little is known about gender differences in evaluation and listing for liver transplantation (LT) in patients with ALD. This is a retrospective review of adult patients with ALD evaluated for LT at a single transplant center from January 1, 2010, to March 1, 2017. Univariate, multivariate, and time-series analyses were performed. Among the 949 patients with ALD evaluated, mean age was 53 years, 84% were Caucasian, and 33% were women. The median model for end-stage liver disease score was similar between the genders. Women were less likely to be listed for LT (10% versus 19%; P < 0.05). The proportion of women not listed due to active substance use was significantly higher versus men (42% versus 35%; P < 0.05), while the frequency of medical contraindications was comparable between the genders. During a median follow-up of 416 days (range: 0-2784), listed women with ALD were less likely to undergo transplantation (42% versus 47%; P < 0.05). Men with ALD were 95% more likely to be listed and 105% more likely to be transplanted compared to women with ALD. While men had more lifetime substance use and related consequences, women had more psychiatric comorbidities and were less likely to be listed due to active alcohol and opioid use. Early detection and effective treatment of psychiatric and substance use disorders in women with ALD may improve their transplant eligibility.
Sections du résumé
BACKGROUND
The morbidity and mortality from alcohol-related liver disease (ALD) is increasing in the United States. However, little is known about gender differences in evaluation and listing for liver transplantation (LT) in patients with ALD.
METHODS
This is a retrospective review of adult patients with ALD evaluated for LT at a single transplant center from January 1, 2010, to March 1, 2017. Univariate, multivariate, and time-series analyses were performed.
RESULTS
Among the 949 patients with ALD evaluated, mean age was 53 years, 84% were Caucasian, and 33% were women. The median model for end-stage liver disease score was similar between the genders. Women were less likely to be listed for LT (10% versus 19%; P < 0.05). The proportion of women not listed due to active substance use was significantly higher versus men (42% versus 35%; P < 0.05), while the frequency of medical contraindications was comparable between the genders. During a median follow-up of 416 days (range: 0-2784), listed women with ALD were less likely to undergo transplantation (42% versus 47%; P < 0.05).
CONCLUSIONS
Men with ALD were 95% more likely to be listed and 105% more likely to be transplanted compared to women with ALD. While men had more lifetime substance use and related consequences, women had more psychiatric comorbidities and were less likely to be listed due to active alcohol and opioid use. Early detection and effective treatment of psychiatric and substance use disorders in women with ALD may improve their transplant eligibility.
Identifiants
pubmed: 31283683
doi: 10.1097/TP.0000000000002843
pii: 00007890-202002000-00017
pmc: PMC8173276
mid: NIHMS1589568
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
293-298Subventions
Organisme : NIAAA NIH HHS
ID : K23 AA026333
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Psychosomatics. 2019 Jan - Feb;60(1):56-65
pubmed: 30122643
Addict Biol. 2016 Sep;21(5):1030-42
pubmed: 27001402
JAMA Psychiatry. 2014 May;71(5):573-81
pubmed: 24806211
Psychosomatics. 2012 Mar-Apr;53(2):123-32
pubmed: 22424160
Alcohol Res Health. 2006;29(1):55-62
pubmed: 16767855
Am J Transplant. 2018 Jan;18 Suppl 1:172-253
pubmed: 29292603
BMJ. 2013 Jan 09;346:e8501
pubmed: 23303891
Am J Transplant. 2019 Jan;19(1):193-203
pubmed: 29878515
JAMA Psychiatry. 2017 Sep 1;74(9):911-923
pubmed: 28793133
Clin Gastroenterol Hepatol. 2017 Aug;15(8):1286-1293.e2
pubmed: 28288834
Hepatology. 2018 Sep;68(3):872-882
pubmed: 29579356
Am J Transplant. 2018 May;18(5):1214-1219
pubmed: 29194969
Aliment Pharmacol Ther. 2014 Nov;40(10):1146-54
pubmed: 25263269
N Engl J Med. 1990 Jan 11;322(2):95-9
pubmed: 2248624
BMJ. 2018 Jul 18;362:k2817
pubmed: 30021785
Health Aff (Millwood). 2013 Oct;32(10):1723-30
pubmed: 24101061
Alcohol Clin Exp Res. 2015 Nov;39(11):2085-94
pubmed: 26500036
Am J Gastroenterol. 2018 Feb;113(2):175-194
pubmed: 29336434
Arch Gen Psychiatry. 2009 Jul;66(7):785-95
pubmed: 19581570
Psychosomatics. 1993 Mar-Apr;34(2):144-53
pubmed: 8456157
Addict Sci Clin Pract. 2014 Aug 27;9:14
pubmed: 25168288
Alcohol Clin Exp Res. 2000 Aug;24(8):1198-201
pubmed: 10968657
Arch Gen Psychiatry. 2007 Jul;64(7):830-42
pubmed: 17606817
JAMA. 2008 Nov 26;300(20):2371-8
pubmed: 19033587